The superior ability of LC-MS/MS to enable documentation of the well-known thyroid hormone-TSH relationship supports the use of this measurement technique in a variety of clinical situations.
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The difficulty inherent in accurately measuring hormones that circulate in low concentrations is well known. Examples of hormones present in low concentrations include testosterone in women (1 ) , estradiol in certain clinical situations (2 ) , and free triiodothyronine (3 ) . Liquid chromatography-tandem mass spectrometry (LC-MS/MS) 5 is a technique that identifies the analyte in a sample by the retention time and the mass-to-charge ratio of parent and fragmentation ions. Quantification of analytes is achieved by determining the ratio of analyte to isotopically labeled (deuterated or carbon-13) internal standard. LC-MS/MS assays are highly accurate and have low limits of detection, and most importantly they are specific for the analyte in question.
LC-MS/MS assays can measure hormones in relatively low concentrations (2, 4, 5 ) . This technique has been shown to be reliable for measuring concentrations of serum testosterone (1, 5 ) , adrenal and gonadal steroids (6, 7 ) , and 25-hydroxyvitamin D (8, 9 ) . LC-MS/MS is more specific than immunoassays for measurement of thyroid hormones, thus making this procedure particularly attractive for thyroid hormone quantification.
We recently described the use of LC-MS/MS to measure thyroid hormones (10 -13 ) , specifically free thyroid hormones after the use of an ultrafiltration step to separate the free hormone. Our studies comparing ultrafiltration LC-MS/MS with use of equilibrium dialysis immunoassay for quantifying free thyroid hormones showed the former to provide essentially identical results to the gold standard approach, Nichols equilibrium dialysis (11, 12 ) . Furthermore, the ultrafiltration procedure can be performed in 30 min, whereas equilibrium dialysis takes 17 h. The precision afforded by the ultrafiltration LC-MS/MS approach is also far superior to that of the older equilibrium dialysis immunoassay method. Ultrafiltration performed at 25°C has excellent correlation with the Nichols equilibrium dialysis immunoassay method (11, 12 ) , whereas at 37°C results for free thyroxine are 1.5 times higher. Other studies investigating the use of LC-MS/ MS, with the alternative use of equilibrium dialysis for separating free and bound thyroid hormone have shown this to be an accurate technique for quantification of free thyroid hormones (14, 15 ) .
The inverse log-linear relationship between thyroid-stimulating hormone (TSH) and free thyroid hormones has been well documented (3, 16 ) . Both thyroxine and triiodothyronine appear to be important for pituitary feedback (3, 17 ) , although opinions differ as to the relative contribution from each of the 2 hormones (18 ) . Triiodothyronine may be the predominant regulator in conditions of autonomous hyperactivity due to nodular thyroid disease (19 ) . The set point of the pituitary-thyroid axis also seems to be individualized (20, 21 ) and is additionally affected by factors such as nutritional status (22) (23) (24) , illness (25 ) , and age (26 ) .
TSH assays are generally accurate and reproducible (3 ). In contrast, the measurement of free thyroid hormones by direct analog immunoassay may be inaccurate (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) . Historically the direct analog immunoassay for the measurement of free thyroid hormones has been criticized as suboptimal, in part because it does not separate the hormones by ultrafiltration or dialysis before analysis. Another criticism is that the assay has poor performance under conditions such as extremes of protein binding (36 ) . Additionally, the presence of interfering thyroid antibodies or heterophilic nonspecific antibodies, which may occur during pregnancy, may contribute to the inaccuracies of immunoassay (33 ) . It has been suggested that immunoassay performance may be worse at low or high thyroid hormone concentrations (35) (36) (37) . LC-MS/MS may perform better in such circumstances (10, 12 ) , and in the case of free thyroxine (FT 4 ), seems to agree better with the gold standard equilibrium dialysis assay (11, 12 ) .
We measured free thyroid hormone concentrations using LC-MS/MS and immunoassay and compared the relationship between the free thyroid hormone concentrations obtained with each assay and the corresponding log-transformed serum TSH concentrations. We hypothesized that LC-MS/MS would provide a more exact representation of the inverse relationship between each of the measured hormones and the log-transformed TSH.
Study Participants, Materials, and Methods

STUDY PARTICIPANTS
The study was approved by the Georgetown University Institutional Review Board and conducted in the General Clinical Research Center (GCRC). Written informed consent was obtained at the initial study visit. There were 4 groups of study participants. Thirty-eight pediatric outpatients Ͻ18 years old each donated 1 sample. These patients were receiving routine medical care, and were suspected by their pediatrician to have hypothyroidism or hyperthyroidism. The adult population consisted of 50 euthyroid patients (ages 18 -65 years) without any chronic medical condition, except for nodular thyroid disease or thyroid cancer, who were scheduled for total or near total thyroidectomy. After their thyroidectomy, study participants were all prescribed a name brand of levothyroxine. Patients with benign thyroid disease (66%) were managed with the goal of achieving TSH concentrations within reference intervals, whereas patients with a diagnosis of thyroid cancer (34%) received therapy to suppress their TSH concentrations. These patients donated 2 blood samples before their thyroidectomy and 2 further samples after thyroidectomy while receiving levothyroxine therapy. Twenty-eight healthy euthyroid women, mean age 37 years, donated a single blood sample each. Ninety-eight healthy euthyroid pregnant women, mean age 33 years, donated blood samples 1-3 times during their pregnancy. The number of samples obtained from pregnant women was 59 during the first trimester, 35 during the second trimester, and 26 during the third trimester. Pregnant women were all taking prenatal multivitamins and had a singleton gestation. Separate analyses based on the nonpediatric populations have already been reported (11, 38, 39 ) .
All samples from pediatric patients were analyzed for FT 4 and free triiodothyronine (FT 3 ) by both immunoassay and LC-MS/MS and TSH. The 200 blood samples from the thyroidectomy cohort were all analyzed for FT 4 by immunoassay and TSH. However, only 121 samples were analyzed for FT 4 by LC-MS/MS, and 52 samples were analyzed for FT 3 by LC-MS/MS. The samples from the 2 groups of women were analyzed for FT 4 by both immunoassay and LC-MS/MS and TSH only. When the 4 patient groups were combined the total number of samples available for analysis was 394. The inclusion of pediatric patients with abnormal TSH values and healthy adults with iatrogenic hyperthy-roidism or hypothyroidism allowed exploration of the log TSH-free thyroid hormone relationship at the 2 extremes of TSH and thyroid hormone concentrations.
THYROID PROFILES
Phlebotomy was performed by the GCRC nursing staff. Samples of 4 mL were collected in plastic red top tubes containing clot activator (Vacutainer®, Becton Dickinson) and allowed to clot for 20 min. After centrifugation the serum was separated and immediately stored at Ϫ80°C before analysis. Levothyroxine administration was delayed until after phlebotomy to obtain trough concentrations of thyroid hormones (40 ) . In addition, patients taking levothyroxine had received a stable dose of levothyroxine for 6 -8 weeks before all thyroid profiles were obtained. Most participants had their thyroid function assessed both by a clinical laboratory and by the GCRC core laboratory, but only the GCRC laboratory results were used in this analysis. A full thyroid profile consisted of serum TSH, FT 4 , and free FT 3 concentrations. However, only the pediatric outpatients and a subset of the healthy adults had their blood samples analyzed for FT 3 .
Each blood sample was analyzed for FT 4 and TSH in the GCRC Bioanalytic Core Laboratory. Some samples with sufficient specimen remaining were also analyzed for FT 3 . Free thyroid hormones were measured both by LC-MS/MS and by direct analog immunoassay. Details of the LC-MS/MS assays have previously been described (10, 12, 13 ) . Briefly, the procedure is based on an online extraction/cleaning of the injected samples with subsequent introduction into the massspectrometer using a built-in Valco switching valve. We injected 400 L of the treated plasma ultrafiltrate onto a Supelco LC-18-DB (3.3 cm ϫ 3.0 mm, 3.0 m particle size) chromatographic column equipped with a Supelco Discovery C-18 (3.0 mm) guard column, where it underwent cleaning with 20% (volume/ volume) methanol in 5 mmol/L ammonium acetate (pH 4.0) at a flow rate of 0.8 mL/min. After 4 min of cleaning the switching valve was activated, the column was flushed with a water/methanol gradient at a flow rate of 0.6 mL/min, and the samples were introduced into the mass spectrometer. The interassay and intraassay imprecision, assessed at 3 different concentrations, yielded CVs Յ7.0% for FT 4 and Յ9.0% for FT 3 .
The pediatric reference intervals (for children age 1-18 years) for FT 4 and FT 3 measured with LC-MS/MS are 11.6 -20.6 pmol/L (0.9 -1.6 ng/dL) and 1.4 -6.2 pmol/L (0.9 -4.0 pg/mL), respectively (10 ) . Adult reference intervals are the same. The calibration range used for FT 4 was 0.5-5.0 ng/dL, the limit of quantification was 0.05 ng/dL, and the limit of detection was 0.025 ng/dL. The calibration range used for FT 3 was immunoassay. This heterogeneous immunoassay has a limit of quantification of 0.2 ng/dL and imprecision Ͻ10% at all concentrations tested, and was calibrated for the range 0.2-6.5 ng/dL The manufacturer's reference range was 11.6 -20.6 pmol/L (0.9 -1.6 ng/dL). FT 3 was assayed with the DPC Immulite 2000 (Siemens). This analog immunoassay has a limit of quantification of 1.0 pg/mL and imprecision Ͻ10% at all concentrations tested, and was calibrated for the range 1-40 pg/ mL. The manufacturer's reference range for this assay was 2.8 -6.5 pmol/L (1.8 -4.2 pg/mL). TSH was also measured with the Dade Dimension RxL Clinical Chemistry Analyzer. This colorimetric immunoassay has a limit of quantification of 0.01 mIU/L and imprecision of Ͻ6.2% at all concentrations tested, and was calibrated for the range 0.01-50 mIU/L. The manufacturer's reference range for this third-generation TSH assay was 0.34 -4.82 mIU/L.
STATISTICAL ANALYSIS
The number of study participants in each population group was not identical. In addition, available sample specimens were not sufficient to measure FT 3 either by LC-MS/MS or immunoassay for all participants.
The relationships between the log-transformed TSH values and each associated thyroid hormone concentration was tested by multiple regression analysis. The relationship was examined for FT 4 and FT 3 measured by 2 different assay methods (immunoassay and LC-MS/MS) in each population and all 4 populations combined. A statistically significant difference between the various TSH-thyroid hormone relationships was tested with regression analysis. Results were considered statistically significant if the P-value was Ͻ0.05. The relationship between log TSH for each hormone was compared for each population and tested for statistically significant differences in slopes and correlations by assessing the interaction between each population and the hormone concentrations in multiple regression analysis.
To gain insight into whether the feedback of free thyroid hormones on TSH production was driven by FT 4 or FT 3 , we attempted to normalize the free thyroid hormone-log TSH slopes. The FT 3 slope was multiplied by 2.4 for LC-MS/MS and 3.4 for immunoassay to reflect the difference in the concentration ranges of the 2 hormones documented during the study. This correction factor was thus an attempt to normalize the range of FT 3 (in pg/mL) to the range of FT 4 (in ng/dL).
Results
The patient populations studied are shown in Table 1 . In each of the 4 populations there was a closer correlation between log TSH and the free thyroid hormones measured by LC-MS/MS than there was between log TSH and the free thyroid hormones measured by immunoassay. These differences were significant for both FT 3 and FT 4 in the pediatric outpatients (Fig. 1) , the healthy adults (Fig. 2) , and the combined population (Fig. 3) . There was no significant difference between the correlation coefficients for the 2 FT 4 assays in the healthy nonpregnant and pregnant populations (Fig.  4) . For the pediatric population the correlations between FT 4 
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were Ϫ0.90 and Ϫ0.82, respectively (P ϭ 0.048). For the same pediatric population the correlations between FT 3 measured by LC-MS/MS and immunoassay were Ϫ0.72 and Ϫ0.57, respectively (P ϭ 0.026). For the healthy adults the correlations for FT 4 measured by LC-MS/MS and immunoassay were Ϫ0.77 and Ϫ0.48, respectively (P Ͻ 0.001). Finally, for the entire population combined the correlations between FT 4 measured by LC-MS/MS and immunoassay were Ϫ0.59 and Ϫ0.48, respectively (P ϭ 0.045).
In addition, there was a better correlation between TSH and FT 4 measured by LC-MS/MS or immunoassay than there was between TSH and FT 3 measured by LC-MS/MS or immunoassay. These differences were significant for FT 4 vs FT 3 in the pediatric outpatients and the healthy adult population. Specifically, for FT 4 vs FT 3 measured by use of LC-MS/MS in the pediatric population the correlations were Ϫ0.90 and Ϫ0.72, respectively (P ϭ 0.023). For FT 4 vs FT 3 measured by immunoassay in the pediatric population the correlations were Ϫ0.82 and Ϫ0.57, respectively (P ϭ 0.012). Finally, for FT 4 vs FT 3 measured with LC-MS/MS in the healthy adult population the correlations were Ϫ0.77 and Ϫ0.68, respectively (P ϭ 0.045).
The relationship between log TSH and FT 4 resulted in a steeper slope than the relationship between log TSH and FT 3 if the slopes were normalized for the full extent of the FT 4 or FT 3 range. In other words, the TSH-FT 3 relationship was relatively blunted compared with the TSH-FT 4 relationship. For LC-MS/MS in the pediatric patients the log TSH-free thyroid hormone slopes were Ϫ0.87 and Ϫ0.67 for FT 4 and FT 3 , respectively (P ϭ 0.023). For immunoassay in the pediatric population the slopes were Ϫ0.73 and Ϫ0.71 for FT 4 and FT 3 , respectively (not significant). Lastly, for LC-MS/MS in the healthy adult population the slopes were Ϫ1.38 and Ϫ0.74 for FT 4 and FT 3 , respectively (P Ͻ 0.001).
When the values obtained for FT 4 measured by LC-MS/MS were directly compared with the values obtained by immunoassay a correlation coefficient of 0.78 was obtained (Fig. 5) . This FT 4 correlation compares unfavorably with the correlation coefficient of 0.95 that we previously documented between FT 4 measured by ultrafiltration LC-MS/MS and the Nichols Institute equilibrium dialysis followed by immunoassay (12 ) . Because insufficient samples were available for which FT 3 was measured by both ultrafiltration LC-MS/MS and immunoassay, we were unable to meaningfully make the same comparison. However, our previously published data show a poor correlation between FT 3 measured by ultrafiltration LC-MS/MS and immunoassay (10 ).
Discussion
Our results illustrate the classic and well-documented inverse log-linear relationship between TSH and free thyroid hormones (3, 16 ) . This relationship was generally seen for both the free thyroid hormones measured in this particular collection of 394 samples, although the relationship was extremely weak in the group of pregnant patients. The most robust relationships were seen for FT 4 measured by LC-MS/MS and immunoassay in the pediatric patients, followed by LC-MS/MS in the healthy adults. However, insufficient specimen samples were available to measure FT 3 by LC-MS/MS or immunoassay in several of the groups for comparison purposes. The total number of samples available for analyzing this analyte (n ϭ 90) was substantially less than for FT 4 (n ϭ 394 samples). The only group with complete FT 3 data available was the small group of pediatric outpatients. In this group FT 3 correlated less with TSH than with FT 4 measured by either assay. However, FT 3 measured by LC-MS/MS had a better correlation with TSH than FT 3 measured by immunoassay. It is unclear why there was little relationship between log TSH and FT 4 in the group of pregnant patients. However, this pattern persisted for both the assays used. Perhaps additional factors are also modulating the pituitary-thyroid axis during pregnancy, or the assays are less accurate during this physiologic state.
FT 3 assays have not been widely used because of the technical difficulties associated with measuring analytes present in low concentrations. In our study an extremely good correlation between FT 3 measured by LC-MS/MS and log TSH was documented. We believe that this provides indirect validation of the accuracy of our recently reported FT 3 LC-MS/MS assay (10 ) . It is possible that under specific circumstances the relationship between FT 3 and TSH is the closest relationship of all.
The close relationship between triiodothyronine and TSH appears to be consistent with a body of evidence, perhaps originating with the study of Fish and colleagues (18 ) , that illustrates the importance of triiodothyronine in regulating serum TSH. Our previous study, in which we used the same healthy adult data discussed here, also showed a close relationship between triiodothyronine and serum TSH (38 ) . Triiodothyronine concentrations appeared to be downregulated when TSH concentrations were lower, suggesting amelioration of the effect of iatrogenic hyperthyroidism by autoregulation of deiodinase activity. After we normalized the log TSH-free thyroid hormone slopes in the LC-MS/MS data for healthy adults, we observed a much less steep slope was seen for the FT 3 -TSH relationship. This suggests that FT 4 plays a more dominant role in feedback inhibition of TSH and that FT 3 concentrations were being downregulated to compensate for hyperthyroidism caused by high levothyroxine doses. There was a similar difference between the slopes for FT 4 and FT 3 LC-MS/MS data for pediatric patients.
When we excluded FT 3 because of the less complete dataset, we observed a closer relationship with the log-transformed TSH when the free hormone was measured by LC-MS/MS. Thus, the correlation coefficient is greatest for FT 4 measured by LC-MS/MS, followed by FT 4 measured by immunoassay. This hierarchy held for all 4 patient populations studied. It is possible that the closer relationship between serum TSH and each of the thyroid hormones measured by LC-MS/MS reflects the greater specificity of LC-MS/ MS. It is also possible that LC-MS/MS performs better at low and high thyroid hormone concentrations. The imprecision of the immunoassays employed was Ͻ10% for both FT 4 and FT 3 at all concentrations tested. In contrast the intraassay and interassay CVs were Ͻ7% and 9% for FT 4 and FT 3 measured by LC-MS/MS, respectively.
Our data regarding the use of LC-MS/MS to measure free thyroid hormones more robustly document the known relationship between TSH and thyroid hormones than do measurements obtained with immunoassays. This accurate representation of the functioning of the pituitary thyroid axis lends support to the premise that LC-MS/MS should become the preferred assay for documenting the concentrations of free thyroid hormones.
